As an accredited provider of continuing medical education, it is the policy of the Educational Review Systems to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. In accordance with this policy, faculty must disclose to the participants any significant relationships with the commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this continuing pharmaceutical education program. The intent of this disclosure is not to prevent a person with a significant financial or other relationship from participating in the planning or review of programs, but rather to provide the intended audience with information on which they can make their own judgments. It remains for the audience to determine whether the interests or relationships of planning committee members, reviewers, or cosponsors may influence the presentation with regard to exposition or conclusion.
Richard G. Stefanacci, DO, MGH, MBA, ASGF, CMD
Speaker Bureau: Pfizer, Ortho McNeil, Abbott, Glaxo Smith Klein, Astra Zeneca, Forest Laboratories*, Amgen*, Merck, Sankyo, Par, Eisai, Schering Plough
Consultant: Celegene, NewCourtland Elder Services, Baxter, Eisai, Pfizer, Sanofi-Aventis, Sepracor, Amgen, Merck, Johnson & Johnson, BMS, Astra Zeneca, Novartis, Wyeth
Grants: American Society of Consultant Pharmacist, Sanofi-Aventis, Amgen, Merck, Forest
Advisory Board: Pfizer, Eisai, Jansen, Solway, Takeda, Genentech, Myrida, Novo Nordisk
Financial Interests: None
*All relationships are for professional services related to the Medicare prescription drug coverage, the Forest Laboratories and Amgen relationship are the only relationships that are related to a specific product.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Med-CE-online.com, ERS, and University of Utah College of Pharmacy do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Med-CE-online.com, ERS, and/or University of Utah College of Pharmacy. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
The entire faculty for this program has reported that they will not discuss unapproved drug or device uses.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.